| Market Cap | 689M 601M 568M 515M 966M 66.16B 970M 6.8B 2.62B 33.63B 2.59B 2.53B 108B | P/E 2026 * |
10.4x | P/E 2027 * | 12.9x |
|---|---|---|---|---|---|
| Enterprise Value | 689M 601M 568M 515M 966M 66.16B 970M 6.8B 2.62B 33.63B 2.59B 2.53B 108B | EV / Sales 2026 * |
4.5x | EV / Sales 2027 * | 3.88x |
| Free-Float |
96.19% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: KemPharm, Inc.
| 1 day | -4.32% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil McFarlane
CEO | Chief Executive Officer | 53 | 09/10/2023 |
Justin Renz
DFI | Director of Finance/CFO | 54 | 08/03/2026 |
Rahsaan Thompson
CMP | Compliance Officer | 55 | 24/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tamara Favorito
CHM | Chairman | 67 | 07/05/2023 |
Douglas Calder
BRD | Director/Board Member | 59 | 24/04/2023 |
Corey Watton
BRD | Director/Board Member | 56 | 24/04/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.32% | +29.70% | - | - | 703M | |
| -0.19% | +2.04% | +80.14% | +36.22% | 363B | |
| -1.22% | -1.22% | +20.85% | -19.25% | 65.62B | |
| +2.53% | +4.90% | +46.65% | +187.52% | 12.45B | |
| -0.29% | +2.94% | -6.00% | -16.54% | 7.6B | |
| -1.89% | -2.14% | -27.99% | -15.17% | 4.49B | |
| -2.06% | -4.41% | -35.13% | +4.31% | 4.19B | |
| +1.48% | +3.64% | -31.47% | -15.12% | 2.92B | |
| -2.14% | +0.86% | -8.95% | +48.36% | 2.49B | |
| -0.41% | +1.15% | -26.86% | -33.47% | 1.93B | |
| Average | -0.85% | +0.46% | +1.25% | +19.65% | 51.64B | |
| Weighted average by Cap. | -0.30% | +1.55% | +65.76% | +30.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 153M 134M 126M 115M 215M 14.71B 216M 1.51B 583M 7.48B 576M 563M 24.06B | 178M 155M 146M 133M 249M 17.05B 250M 1.75B 676M 8.67B 668M 653M 27.89B |
| Net income | 68.14M 59.42M 56.11M 50.95M 95.46M 6.54B 95.85M 672M 259M 3.32B 256M 250M 10.7B | 55.27M 48.2M 45.51M 41.32M 77.43M 5.3B 77.75M 545M 210M 2.7B 208M 203M 8.68B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
